Siddharthan Chandran

Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.

Part of Baillie Gifford & Co., Baillie Gifford International LLC is an independent investment partnership founded in Edinburgh in 1908. The company is based in Edinburgh, UK. The British company focuses on long-term growth investing in some of the world's most exciting companies. With assets under management of £230bn and 1,800 staff, the company has offices in various locations. Baillie Gifford International is unique in being a large-scale investment business that has remained an independent private partnership.

SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA.

SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

Novasite Pharmaceuticals, Inc. develops optimizing genes and proteins. The private company is based in San Diego, CA and has subsidiaries in United States. The company was founded by Juan Antonio Ballesteros Nobell.

Part of Leidos Holdings, Inc., SAIC-Frederick, Inc. provides technical solutions and services. The company is based in San Diego, CA. David Heimbrook has been the CEO of the company since 2011.

Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada.

Part of Samsung Electronics Co., Ltd., Duran Audio BV is a Dutch company that manufactures and distributes audio equipment. The company is based in Zaltbommel, the Netherlands. Duran Audio was acquired by Harman International Industries, Inc., part of Samsung Electronics Co., Ltd. from March 13, 2017 on October 17, 2013 for $40.47 million.

Standard Property Investment Ltd. provides property development services. The company is headquartered in London, the United Kingdom.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Gaithersburg, MD.

Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom.

Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples.

Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff.

Founded in 1980, Hydrainer Pump Hire Ltd. is a British company that leases hydraulic and electronic submersible pumps. Part of Hydrainer Holdings Ltd., the company is based in Killamarsh, UK.

Orrmac (No 50) Ltd. is an investment holding British company founded in 1986. The private company is based in Edinburgh, UK.

Aston Tower Multi-Academy Trust is a British educational institution management company founded in 2016. The non-profit company is based in Birmingham, UK. The company manages educational institutions.

Pencil Biosciences Ltd. develops gene modulation technology. The company was founded on November 5, 2018 and is headquartered in Macclesfield, the United Kingdom.

Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium.

Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom.

Baillie Gifford International LLC (BGI) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2005 and is a wholly owned subsidiary of Baillie Gifford Overseas Ltd. (BGO), which is owned by Baillie Gifford & Co. in Great Britain. BGI serves as the investment manager for pooled investment vehicles, which includes the Group Trust and Private Companies Fund.

Turbine Simulated Cell Technologies Ltd. is a British company that leverages AI technology to understand oncology patients with simulated cells. The company is based in London, UK. and has subsidiaries in Hungary. The company was founded in 2019 by Szabolcs Nagy, Ivan Fekete, Daniel Veres, Kristof Zsolt Szalay. Szabolcs Nagy has been the CEO since 2019.

Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation.

Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021.

Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.